As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two main factors: human resources and finance. On one side, there's the potential ...

Like everything else in modern life, the landscape of food, health and nutrition is always evolving. Every year, there’s a ...

A UK biotechnology startup is entering the crowded obesity drug market, armed with $411 million and a promising ...

Read the article below to know if Jonathan Van Ness is taking a weight loss medication as he makes a revelation about his ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

The rise in medication usage for weight loss unlocks opportunities for innovation in health-focused products and services, the Circana report found.

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...